{"protocolSection":{"identificationModule":{"nctId":"NCT04774341","orgStudyIdInfo":{"id":"20210225"},"organization":{"fullName":"Center of Personalized Medicine, Pirogova","class":"OTHER"},"briefTitle":"Personalized Evidence-based Medicine in Patients With Atrial Fibrillation","officialTitle":"Personalized Evidence-based Medicine Improves Outcomes of Anticoagulation Therapy in Patients With Atrial Fibrillation"},"statusModule":{"statusVerifiedDate":"2021-02","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-01-10","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2021-02-24","type":"ACTUAL"},"completionDateStruct":{"date":"2021-02-24","type":"ACTUAL"},"studyFirstSubmitDate":"2021-02-24","studyFirstSubmitQcDate":"2021-02-24","studyFirstPostDateStruct":{"date":"2021-03-01","type":"ACTUAL"},"lastUpdateSubmitDate":"2021-02-26","lastUpdatePostDateStruct":{"date":"2021-03-02","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Evgeny Pookushalov","investigatorTitle":"Director for research and development","investigatorAffiliation":"Center of Personalized Medicine, Pirogova"},"leadSponsor":{"name":"Center of Personalized Medicine, Pirogova","class":"OTHER"},"collaborators":[{"name":"Center for New Medical Technologies, Novosibirsk, Russia","class":"OTHER"},{"name":"I.M. Sechenov First Moscow State Medical University","class":"OTHER"},{"name":"University of Rochester","class":"OTHER"},{"name":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"A retrospective analysis","detailedDescription":"4200 EMR of patients at high risk for stroke with 1-year follow-up will be enrolled in the current study and analyzed by clinical decision support systems (CDSS MedicBK) utilizing a core laboratory."},"conditionsModule":{"conditions":["Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke"],"keywords":["Atrial fibrillation","Personalized evidence-based medicine","Clinical decision support systems","Stroke","Anticoagulation","Guidelines"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"RETROSPECTIVE"},"enrollmentInfo":{"count":4200,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"CDSS (MedicBK) Analysis","interventionNames":["Drug: anticoagulation treatment"]},{"label":"Core Laboratory Analysis","interventionNames":["Drug: anticoagulation treatment"]}],"interventions":[{"type":"DRUG","name":"anticoagulation treatment","description":"Adherence to personalized evidence-based anticoagulant treatment in patients at high risk for stroke with atrial fibrillation","armGroupLabels":["CDSS (MedicBK) Analysis","Core Laboratory Analysis"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"The percentage of guideline-based and personalized EBM recommendations","description":"The percentage of guideline-based and personalized EBM recommendations acted on by clinicians for anticoagulant therapy in patients with AF. All discrepancies between routine and CDSS-recommended treatment resulting in frame of guideline-based therapy and personalized EBM therapy will be adjudicated by core laboratory.","timeFrame":"1-year"}],"secondaryOutcomes":[{"measure":"Quantify the performance of the CDSS (MedicBK) algorithm","description":"Quantify the performance of the CDSS (MedicBK) algorithm for presents treatment suggestions in frame of guideline-based therapy and personalized EBM therapy: the sensitivity, specificity, NPV, and PPV","timeFrame":"1-year"},{"measure":"1-year FU outcomes","description":"Outcomes for all-cause mortality, thromboembolism (TE), bleeding, and the composite endpoint of any thromboembolism, cardiovascular death, or bleeding in relation to whether they were guideline-based treatment or personalized EBM treatment. Thromboembolism refers to stroke, transient ischemic attack, acute coronary syndrome, coronary intervention, cardiac arrest, peripheral embolism, and pulmonary embolism","timeFrame":"1-year"},{"measure":"Predictors","description":"Predictors of guideline-based and personalized EBM adherence","timeFrame":"1-year"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nEMR only if an ECG diagnosis (12-lead ECG, 24-h Holter, or other electrocardiographic documentation) confirming AF was made in patients at high risk for stroke by CHA2DS2-VASc (≥2 in men and ≥3 in women).\n\nExclusion Criteria:\n\nNo","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"],"studyPopulation":"Patients at high risk for stroke with atrial fibrillation","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Evgeny Pokushalov, Prof. MD PhD","affiliation":"Center for New Medical Technologies, Novosibirsk, Russia","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Evgeny Pokushalov","city":"Novosibirsk","zip":"630090","country":"Russian Federation","geoPoint":{"lat":55.0415,"lon":82.9346}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M3934","name":"Anticoagulants","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnCoag","name":"Anticoagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}